Thank You for Registering

You will shortly be receiving an automatic email confirming your online registration and within the next 24 hours, you will receive your invoice and/or payment confirmation. We look forward to welcoming you to the conference.

Book your accommodation here

If you have any questions about your registration, please contact

Telephone: +1 617 455 4188 or +44 (0)20 3141 8700

Spread the Word

Make the most of your time at the 9th CAR-TCR Summit by sharing your attendance ahead of time,
so that your colleagues and network can join you there!

Simply right click on the below banner to save and share on LinkedIn:

Poster Session!

Showcase your research, presenting a poster is reserved exclusively for drug developers, academics & clinicians.

Posters will be displayed for the duration of the conference with dedicated poster sessions in the agenda too.

Hotel Room Blocks

Registered Attendees Can Access Discounted Hotel Rates Here!

Hilton Boston Back Bay

Standard Rate: $569++

CAR-TCR Summit Rate: $439++

To reserve your rooms at the Hilton Boston Back Bay please follow the link here.

Please be aware we have had reports of unsolicited contact from 3rd party companies regarding accommodation. Please read our policy here:

Registered Attendees Policy: These exclusive hotel rates and rooms are onlt for the attendees of CAR-TCR Summit 2024 (participants, exhibitors, sponsors, speakers and other invited guests). The organizers and the hotels reserve the right to cancel any hotel bookings made by persons who are not attending this event

Continue Your Cell Therapy Journey


Cell Therapy

Delivering Safer, More Effective & Globally Accessible Cell Therapies to Patients at Scale


Our Cell Therapy conferences aim to supercharge durable, safe, and cost-effective cell therapies for patients. We focus on helping overcome the discovery, translational, clinical, and commercial hurdles to realize cell therapies for patients at scale.


Beacon's cell therapy database covers trial and drug records for preclinical, active, approved, and discontinued CAR (chimeric antigen receptor) modified therapies, TCR (T-Cell Receptor) therapies, natural killer cells, tumor-infiltrating lymphocytes cytokine-induced killer cells, dendritic cells, and macrophages.


A year-round experience-sharing and problem-solving network helping drug developers address critical R&D challenges in CAR-TCR therapies for solid tumors. 


A trusted provider of market intelligence for anyone looking to understand the complexities of cell therapy research and development.